BD Introduces New Product To Reduce The Risk Of Sepsis
Zacks Investment Research | Apr 08, 2019 09:51PM ET
Becton, Dickinson and Company (NYSE:BDX) , popularly known as BD, recently introduced BD BACTEC platelet control media that will enable microbiology laboratories, blood banks and transfusion services in the identification of contaminated platelet units. This new quality control media is likely to significantly broaden the scope of the company’s BACTEC portfolio.
The company is optimistic about reducing the occurrence of sepsis among patients requiring blood transfusion following the introduction of this product. BD also claims that this new quality control media will decrease the patient’s expenses owing to sepsis.
BD BACTEC platelet control media, which is an FDA cleared product, will help in carrying on the company’s legacy in providing specific and cost-effective solutions through BD BACTEC portfolio.
Platelet Transfusion and Sepsis at a Glance
Platelet transfusion is a process wherein platelets are transferred to patients having low platelet counts or those who have platelet dysfunction and are bleeding or at a high risk of bleeding.
Going by Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.